With the state taking major strides in the pharma sector, Gujarat University is coming up with a major initiative to provide human resource workforce for clinical research. In what is being touted as a first-of-its kind programme, the varsity will soon start a course in clinical research.
Gujarat University vice-chancellor Dr Parimal Trivedi said that the post graduate and diploma courses in clinical research will begin from this academic year. "It's a major initiative that will open avenues to the students in the field of clinical research,'' said Dr Trivedi.
Students who have completed their graduation in medical, dental and pharma streams can apply for the course. Even B.Sc physiotherapy and paramedical courses degree holders can apply. MSc in clinical research, post graduate diploma in clinical research and clinical trial management and post graduate diploma in regulatory affairs are some of the post graduate courses that will be offered at the university. The courses will be taught in three semesters, and the student strength will be 50 per course.
Speaking on the fee structure, Dr Trivedi said that for regular seats Rs40,000 will be charged, for special seats the fee would be Rs 50,000.
"Also Rs 1000 will be collected as examination fee per semester,'' he said.
Students who have secured 45% aggregate marks at least can apply for the course. The admission will be conducted through written examinations and the students will be selected on the basis of merit.
Dr Trivedi believes that such a unique course will not only help the pharma sector in getting the required manpower for research work, but would also help students to explore new avenues in the field of clinical research. The course will also include practical exercises of clinical trial activities. "I understand that it's a one of its kind course in the country, which will help the students immensely,'' he said.
The most interesting feature, according to university officials, would be the course pertaining to regulatory affairs, which has been a matter of debate in the past on how ethical practices should be effectively incorporated in the field of clinical research.